ALL
Clinical trials for ALL explained in plain language.
Never miss a new study
Get alerted when new ALL trials appear
Sign up with your email to follow new studies for ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells show promise against hard-to-treat childhood blood cancers
Disease control CompletedThis study tested a new treatment for children and young adults (ages 1-39) with B-cell leukemia or lymphoma that did not respond to standard therapy. Researchers took participants' white blood cells, modified them in a lab to target the CD22 protein on cancer cells, and infused …
Matched conditions: ALL
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:12 UTC
-
Ashwagandha herb put to the test: 12-Month safety check completed
Knowledge-focused CompletedThis study checked the safety of a popular herbal supplement called KSM-66 ashwagandha when taken for a full year. Researchers followed 200 adults who were already prescribed this herb by their doctor. They tracked any side effects and ran lab tests to see how the body handled lo…
Matched conditions: ALL
Sponsor: SF Research Institute, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 08:15 UTC